- Home
- ADAG vs EVF Comparison
ADAG vs EVF Comparison
Compare ADAG & EVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADAG | EVF |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.8M | 95.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADAG | EVF |
|---|---|---|
| Price | $1.83 | $5.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | 53.1K | ★ 93.3K |
| Earning Date | 08-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.68% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.94 |
| Revenue | ★ $103,204.00 | N/A |
| Revenue This Year | $6,983.06 | N/A |
| Revenue Next Year | $36.05 | N/A |
| P/E Ratio | ★ N/A | $6.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.30 | $5.20 |
| 52 Week High | $3.16 | $6.84 |
Technical Indicators
Market Signals| Indicator | ADAG | EVF |
|---|---|---|
| Relative Strength Index (RSI) | 46.90 | 40.94 |
| Support Level | $1.76 | $5.32 |
| Resistance Level | $1.93 | $5.32 |
| Average True Range (ATR) | 0.14 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 50.00 | 32.97 |
Price Performance
Historical ComparisonAbout ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.